Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06554600
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-08-07
Brief Title:
A Study of Zanubrutinib in Combination With Polatuzumab Vedotin Bendamustine and Rituximab in the Treatment of RelapsedRefractory Diffuse Large B-cell Lymphoma
Sponsor:
Organization:
None